Company PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Business description: PCL, Inc.

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 22

Sales by Activity: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Vitro Diagnostics-Related Business	53.68B	46.15B	37.22B	8.43B	1.25B

See all business segments

Geographical breakdown of sales: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	3.91B	599M	28.13B	2.92B	1.17B
Other	-	-	-	138M	34.09M
Asia	-	-	-	3.87B	19.75M
Europe	-	-	-	1.48B	-
Overseas	49.77B	45.55B	9.08B	-	-

See all geographic segments

Executive Committee: PCL, Inc.

Manager	Title	Age	Since
So-Yeon Kim CEO	Chief Executive Officer	55	-
Seong-Woo Lee SAM	Sales & Marketing	42	28/03/2024
Mu-Yong So AUD	Comptroller/Controller/Auditor	53	28/03/2024
Won-Hee Jang AUD	Comptroller/Controller/Auditor	53	31/03/2025
Seung-Ki Hong AUD	Comptroller/Controller/Auditor	72	-

See PCL, INC. governance

Composition of the Board of Directors: PCL, Inc.

Director	Title	Age	Since
So-Yeon Kim BRD	Director/Board Member	55	-
Chul-Joon Kim BRD	Director/Board Member	74	-
Mu-Yong So BRD	Director/Board Member	53	28/03/2024
Seong-Woo Lee BRD	Director/Board Member	42	28/03/2024
Dae-Yeol Kim BRD	Director/Board Member	49	31/03/2023

Composition of the Board of Directors

Company details: PCL, Inc.

PCL, Inc.

99 Digital-ro 9-gil

08510, Seoul

http://www.pclchip.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCL, INC.	-1.63%	-.--%	-.--%	-89.21%	12.32M
WUXI APPTEC CO., LTD.	+2.24%	+5.83%	+58.47%	+65.65%	66.7B
ARGENX SE	+4.66%	+5.77%	+16.93%	+82.87%	56.88B
LONZA GROUP AG	-0.60%	+2.36%	+24.32%	+97.19%	56.53B
BEONE MEDICINES AG	+2.77%	+15.83%	+27.12%	+120.77%	46.49B
IQVIA HOLDINGS INC.	+2.53%	+7.87%	+30.85%	+45.26%	44.8B
REVOLUTION MEDICINES, INC.	+4.09%	+6.60%	+219.78%	+901.97%	41.59B
CELLTRION, INC.	-0.47%	+9.60%	+27.53%	+52.88%	35.35B
GENMAB A/S	+3.80%	-6.42%	+98.16%	+68.09%	33.29B
INSMED INCORPORATED	+1.55%	+5.48%	-39.92%	+392.31%	25.1B
Average	+1.90%	+2.61%	+46.32%	+173.78%	40.67B
Weighted average by Cap.	+2.37%	+3.97%	+52.27%	+181.25%